These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sequential 1H NMR assignments of kistrin, a potent platelet aggregation inhibitor and glycoprotein IIb-IIIa antagonist. Adler M, Wagner G. Biochemistry; 1992 Feb 04; 31(4):1031-9. PubMed ID: 1734953 [Abstract] [Full Text] [Related]
6. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Lu X, Williams JA, Deadman JJ, Salmon GP, Kakkar VV, Wilkinson JM, Baruch D, Authi KS, Rahman S. Biochem J; 1994 Dec 15; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494 [Abstract] [Full Text] [Related]
10. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA. Proc Natl Acad Sci U S A; 1990 Apr 15; 87(7):2471-5. PubMed ID: 2320569 [Abstract] [Full Text] [Related]
11. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa). Podolnikova NP, Gorkun OV, Loreth RM, Yee VC, Lord ST, Ugarova TP. Biochemistry; 2005 Dec 27; 44(51):16920-30. PubMed ID: 16363805 [Abstract] [Full Text] [Related]
12. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV. Biokhimiia; 1996 Mar 27; 61(3):412-28. PubMed ID: 8724599 [Abstract] [Full Text] [Related]
15. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold. Lee G, Chan W, Hurle MR, DesJarlais RL, Watson F, Sathe GM, Wetzel R. Protein Eng; 1993 Sep 27; 6(7):745-54. PubMed ID: 8248098 [Abstract] [Full Text] [Related]
16. Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence. Jing J, Lu S. Biotechnol Lett; 2005 Sep 27; 27(17):1259-65. PubMed ID: 16215822 [Abstract] [Full Text] [Related]
17. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR. Infect Immun; 1995 Sep 27; 63(9):3634-41. PubMed ID: 7642301 [Abstract] [Full Text] [Related]
18. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. Wang WJ, Huang TF. Thromb Haemost; 2001 Oct 27; 86(4):1077-86. PubMed ID: 11686327 [Abstract] [Full Text] [Related]
19. Inhibition of platelet-vessel wall interaction. Platelet receptors, monoclonal antibodies, and synthetic peptides. Ruggeri ZM. Circulation; 1990 Jan 27; 81(1 Suppl):I35-9; discussion I40-1. PubMed ID: 2403866 [Abstract] [Full Text] [Related]
20. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation. Rahman S, Aitken A, Flynn G, Formstone C, Savidge GF. Biochem J; 1998 Oct 15; 335 ( Pt 2)(Pt 2):247-57. PubMed ID: 9761721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]